Current insights into the regulation of programmed cell death by NF-κB

Oncogene

Volumn 25, Issue 51, 2006, Pages 6800-6816

  Dutta, J ^a,b   Fan, Y ^a   Gupta, N ^a,b   Fan, G ^a,b   Gelinas C ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c CABM   (United States)

Author keywords

Apoptosis; Cancer; Necrosis; NF kappaB; Transcription factor

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; BORTEZOMIB; CAMPTOTHECIN; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; ONCOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; BREAST CANCER; BREAST TUMOR; CANCER; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CELLULAR DISTRIBUTION; DRUG INHIBITION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INFLAMMATION; MEMORY DISORDER; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPINAL CORD INJURY; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR GROWTH; VIRUS INFECTION; VIRUS TRANSFORMATION;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, VIRAL; HOMEOSTASIS; HUMANS; NECROSIS; NF-KAPPA B;

EID: 33750475618     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209938     Document Type: Review

References (246)

1. Abraham MC, Shaham S. (2004). Trends Cell Biol 14: 184-193.
2. Aguilera C, Hoya-Arias R, Haegeman G, Espinosa L, Bigas A. (2004). Proc Natl Acad Sci USA 101: 16537-16542.
3. Albensi BC, Mattson MP. (2000). Synapse 35: 151-159.
4. Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M et al. (2001). J Immunol 167: 1592-1600.
5. Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A et al. (2000). Nature 403: 503-511.
6. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A et al. (2003). Nature 424: 741.
7. Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB. (2004). Biochem Pharmacol 67: 353-364.
8. Baetu TM, Kwon H, Sharma S, Grandvaux N, Hiscott J. (2001). J Immunol 167: 3164-3173.
9. Baetz D, Regula KM, Ens K, Shaw J, Kothari S, Yurkova N et al. (2005). Circulation 112: 3777-3785.
10. Bailey ST, Ghosh S. (2005). Nat Immunol 6: 966-967.
11. Baldwin AS. (2001). J Clin Invest 107: 241-246.
12. Bargou R, Emmerich F, Krappmann D, Bommert K, Mapara M, Arnold W et al. (1997). J Clin Invest 100: 2961-2969.
13. Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. (2003). Blood 101: 3681-3686.
14. Basseres D, Baldwin AS. (2006). Oncogene 25: 6817-6830.
15. Beg AA, Baltimore D. (1996). Science 274: 782-784.
16. Benezra M, Chevallier N, Morrison D, MacLachlan T, El-Deiry WS, Licht JD. (2003). J Biol Chem 278: 26333-26341.
17. Bernard D, Monte D, Vandenbunder B, Abbadie C. (2002). Oncogene 21: 4392-4402.
18. Bernard D, Quatannens B, Begue A, Vandenbunder B, Abbadie C. (2001a). Cancer Res 61: 2656-2664.
19. Bernard D, Quatannens B, Vandenbunder B, Abbadie C. (2001b). J Biol Chem 276: 27322-27328.
20. Bertoni F, Zucca E. (2006). J Clin Invest 116: 22-26.
21. Beyaert R, Heyninck K, Van Huffel S. (2000). Biochem Pharmacol 60: 1143-1151.
22. Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M et al. (2000). EMBO J 19: 4976-4985.
23. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S et al. (2005). J Exp Med 202: 145-156.
24. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. (2003). J Virol 77: 8532-8540.
25. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. (2003). Nature 424: 797-801.
26. Bubici C, Papa S, Dean K, Franzoso G. (2006). Oncogene 25: 6731-6748.
27. Budd RC, Yeh WC, Tschopp J. (2006). Nat Rev Immunol 6: 196-204.
28. Burstein E, Ganesh L, Dick RD, van De Sluis B, Wilkinson JC, Klomp LW et al. (2004). EMBO J 23: 244-254.
29. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, Komarck CM et al. (2005). J Biol Chem 280: 22222-22232.
30. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E. (2000). Proc Natl Acad Sci USA 97: 6055-6060.
31. Campbell KJ, O'Shea JM, Perkins ND. (2006a). BMC Cancer 6: 101.
32. Campbell KJ, Rocha S, Perkins ND. (2004). Mol Cell 13: 853-865.
33. Campbell KJ, Witty JM, Rocha S, Perkins ND. (2006b). Cancer Res 66: 929-935.
34. Catz SD, Johnson JL. (2001). Oncogene 20: 7342-7351.
35. Cavin LG, Venkatraman M, Factor VM, Kaur S, Schroeder I, Mercurio F et al. (2004). Cancer Res 64: 7030-7038.
36. Chan H, Bartos DP, Owen-Schaub LB. (1999). Mol Cell Biol 19: 2098-2108.
37. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. (2006). Cell 124: 601-613.
38. Chen C, Edelstein LC, Gélinas C. (2000). Mol Cell Biol 20: 2687-2695.
39. Chen F, Castranova V, Li Z, Karin M, Shi X. (2003a). Cancer Res 63: 7689-7693.
40. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. (2005). Mol Cell 17: 393-403.
41. Chen X, Kandasamy K, Srivastava RK. (2003b). Cancer Res 63: 1059-1066.
42. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. (1997). Proc Natl Acad Sci USA 94: 10057-10062.
43. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, Richardson JA et al. (2005). Proc Natl Acad Sci USA 102: 12885-12890.
44. Claudio E, Brown K, Siebenlist U. (2006). Cell Death Differ 13: 697-701.
45. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS. (2000). Oncogene 19: 1123-1131.
46. Collart MA, Baeuerle PA, Vassalli P. (1990). Mol Cell Biol 10: 1498-1506.
47. Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H et al. (2005). Toxicol Pathol 33: 726-737.
48. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ et al. (2003). Nature 421: 639-643.
49. Danial NN, Korsmeyer SJ. (2004). Cell 116: 205-219.
50. Davis RE, Brown KD, Siebenlist U, Staudt LM. (2001). J Exp Med 194: 1861-1874.
51. Davis RJ. (2000). Cell 103: 239-252.
52. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al. (2001). Nature 414: 308-313.
53. de Visser KE, Coussens LM. (2005). Cancer Immunol Immunother 54: 1143-1152.
54. Delhalle S, Deregowski V, Benoit V, Merville MP, Bours V. (2002). Oncogene 21: 3917-3924.
55. Denk A, Wirth T, Baumann B. (2000). Cytokine Growth Factor Rev 11: 303-320.
56. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM et al. (1998). EMBO J 17: 2215-2223.
57. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ et al. (1999). Proc Natl Acad Sci USA 96: 2994-2999.
58. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB et al. (2002). Nat Med 8: 793-800.
59. Duckett CS. (2005). Biochem J 385: e1-e2.
60. Eckelman BP, Salvesen GS. (2006). J Biol Chem 281: 3254-3260.
61. Edinger AL, Thompson CB. (2004). Curr Opin Cell Biol 16: 663-669.
62. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM et al. (2004). Proc Natl Acad Sci USA 101: 2452-2457.
63. Fan Y, Dutta J, Gupta N, Fan G, Gélinas C. (2006a). In: Khosravi-Far R, White E (eds). Programmed Cell Death in Cancer Progression and Therapy. Springer: The Netherlands, in press.
64. Fan Y, Dutta J, Gupta N, Gélinas C. (2006b). In: Liou H-C (ed). NF-κB/Rel Transcription Factor Family. Landes Bioscience Publishers: Georgetown, TX, pp 112-130.
65. Feng B, Cheng S, Hsia CY, King LB, Monroe JG, Liou HC. (2004). Cell Immunol 232: 9-20.
66. Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G et al. (2005). Blood 106: 1392-1399.
67. Feuillard J, Schuhmacher M, Kohanna S, Asso-Bonnet M, Ledeur F, Joubert-Caron R et al. (2000). Blood 95: 2068-2075.
68. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J et al. (2003). J Neurosci 23: 9403-9408.
69. Ganesh L, Yoshimoto T, Moorthy NC, Akahata W, Boehm M, Nabel EG et al. (2006). Mol Cell Biol 26: 3864-3874.
70. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E et al. (2004). Nature 428: 328-332.
71. Gerondakis S, Strasser A. (2003). Semin Immunol 15: 159-166.
72. Gilmore T, Gapuzan ME, Kalaitzidis D, Starczynowski D. (2002). Cancer Lett 181: 1-9.
73. Gilmore TD, Herscovitch M. (2006). Oncogene 25: 6887-6899.
74. Gilmore TD. (1999). Oncogene 18: 6925-6937.
75. Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME. (2001). Oncogene 20: 7098-7103.
76. Goudeau B, Huetz F, Samson S, Di Santo JP, Cumano A, Beg A et al. (2003). Proc Natl Acad Sci USA 100: 15800-15805.
77. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). Cell 118: 285-296.
78. Grimm T, Schneider S, Naschberger E, Huber J, Guenzi E, Kieser A et al. (2005). Blood 105: 3263-3269.
79. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. (2000). EMBO J 19: 6351-6360.
80. Grumont RJ, Rourke IJ, Gerondakis S. (1999). Genes Dev 13: 400-411.
81. Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W et al. (1998). J Exp Med 187: 663-674.
82. Guasparri I, Keller SA, Cesarman E. (2004). J Exp Med 199: 993-1003.
83. Gugasyan R, Christou A, O'Reilly LA, Strasser A, Gerondakis S. (2006). Cell Death Differ 13: 1235-1237.
84. Harhaj EW, Good L, Xiao G, Sun S-C. (1999). Oncogene 18: 1341-1349.
85. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. (2001). Mol Cell Biol 21: 3604-3608.
86. Hayden MS, West AP, Ghosh G. (2006). Oncogene 25: 6758-6780.
87. He Z, Xin B, Yang X, Chan C, Cao L. (2000). Cancer Res 60: 1845-1848.
88. Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C. (2001). Blood 97: 2798-2807.
89. Hiscott J, Nguyen T-LA, Arguello M, Nakhaei P, Paz S. (2006). Oncogene 25: 6844-6867.
90. Hiscott J, Kwon H, Genin P. (2001). J Clin Invest 107: 143-151.
91. Ho WC, Dickson KM, Barker PA. (2005). Cancer Res 65: 4273-4281.
92. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. (2000). Nature 406: 86-90.
93. Hrdlicková R, Nehyba J, Liss AS, Bose Jr HR. (2006). J Virol 80: 281-295.
94. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. (2006a). Mol Cell Biol 26: 3071-3084.
95. Hu S, Du MQ, Park SM, Alcivar A, Qu L, Gupta S et al. (2006b). J Clin Invest 116: 174-181.
96. Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA et al. (2000). J Biol Chem 275: 9501-9509.
97. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. (2003). Cell 115: 565-576.
98. Ikeda F, Dikic I. (2006). Cell 125: 643-645.
99. Jaattela M, Tschopp J. (2003). Nat Immunol 4: 416-423.
100. Jacque E, Tchenio T, Piton G, Romeo PH, Baud V. (2005). Proc Natl Acad Sci USA 102: 14635-14640.
101. Janssens S, Tinel A, Lippens S, Tschopp J. (2005). Cell 123: 1079-1092.
102. Jin R, De Smaele E, Zazzeroni F, Nguyen DU, Papa S, Jones J et al. (2002). DNA Cell Biol 21: 491-503.
103. John GR, Lee SC, Brosnan CF. (2003). Neuroscientist 9: 10-22.
104. Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK et al. (2004). J Biol Chem 279: 36171-36174.
105. Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD. (2002). Oncogene 21: 8759-8768.
106. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prullage M et al. (2006). Mol Cell Biol 26: 2936-2946.
107. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. (2005). Cell 120: 649-661.
108. Kang SJ, Wang S, Hara H, Peterson EP, Namura S, Amin-Hanjani S et al. (2000). J Cell Biol 149: 613-622.
109. Karin M, Cao Y, Greten FR, Li ZW. (2002). Nat Rev Cancer 2: 301-310.
110. Karin M, Lin A. (2002). Nat Immunol 3: 221-227.
111. Kashatus D, Cogswell P, Baldwin AS. (2006). Genes Dev 20: 225-235.
112. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. (1998). Mol Cell 1: 543-551.
113. Kasibhatla S, Genestier L, Green DR. (1999). J Biol Chem 274: 987-992.
114. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC et al. (2001). Oncogene 20: 7965-7975.
115. Kaur S, Wang F, Venkatraman M, Arsura M. (2005). J Biol Chem 280: 38599-38608.
116. Kawakami H, Tomita M, Matsuda T, Ohta T, Tanaka Y, Fujii M et al. (2005). Int J Cancer 115: 967-974.
117. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ et al. (2006). Blood 107: 3295-3302.
118. Kim SJ, Hwang SG, Shin DY, Kang SS, Chun JS. (2002). J Biol Chem 277: 33501-33508.
119. Kopp E, Ghosh S. (1994). Science 265: 956.
120. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. (2000). Leukemia 14: 399-402.
121. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. (2003). Nature 424: 801-805.
122. Kralova J, Liss AS, Bargmann W, Pendleton C, Varadarajan J, Ulug E et al. (2002). J Virol 76: 11960-11970.
123. Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O et al. (2004). J Cell Biol 166: 369-380.
124. Kreuz S, Siegmund D, Scheurich P, Wajant H. (2001). Mol Cell Biol 21: 3964-3973.
125. Krikos A, Laherty CD, Dixit VM. (1992). J Biol Chem 267: 17971-17976.
126. Kucharczak JF, Simmons MJ, Fan Y, Gélinas C. (2003). Oncogene 22: 8961-8982.
127. Lamsoul I, Lodewick J, Lebrun S, Brasseur R, Burny A, Gaynor RB et al. (2005). Mol Cell Biol 25: 10391-10406.
128. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. (2005). Oncogene 24: 5137-5148.
129. Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G. (1999a). Proc Natl Acad Sci USA 96: 9136-9141.
130. Lee RM, Gillet G, Burnside J, Thomas SJ, Neiman P. (1999b). Genes Dev 13: 718-728.
131. Lee SK, Seo SH, Kim BS, Kim CD, Lee JH, Kang JS et al. (2005). J Dermatol Sci 40: 95-103.
132. Leist M, Jaattela M. (2001). Nat Rev Mol Cell Biol 2: 589-598.
133. Levenson JM, Choi S, Lee SY, Cao YA, Ahn HJ, Worley KC et al. (2004). J Neurosci 24: 3933-3943.
134. Li Q, Estepa G, Memet S, Israël A, Verma IM. (2000). Genes Dev 14: 1729-1733.
135. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC et al. (1999). Genes Dev 13: 1322-1328.
136. Li Q, Verma IM. (2002). Nat Rev Immunol 2: 725-734.
137. Lin A, Karin M. (2003). Semin Cancer Biol 13: 107-114.
138. Liston P, Fong WG, Korneluk RG. (2003). Oncogene 22: 8568-8580.
139. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G et al. (1996). Nature 379: 349-353.
140. Liu N, Raja SM, Zazzeroni F, Metkar SS, Shah R, Zhang M et al. (2003). EMBO J 22: 5313-5322.
141. Lotze MT, Tracey KJ. (2005). Nat Rev Immunol 5: 331-342.
142. Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J et al. (2003). Proc Natl Acad Sci USA 100: 15595-15600.
143. Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E et al. (2004). Proc Natl Acad Sci USA 101: 141-146.
144. Luo JL, Kamata H, Karin M. (2005). J Clin Immunol 25: 541-550.
145. Malewicz M, Zeller N, Yilmaz ZB, Weih F. (2003). J Biol Chem 278: 32825-32833.
146. Massoumi R, Podda M, Fassler R, Paus R. (2006). J Invest Dermatol 126: 1182-1184.
147. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST. (1998). J Immunol 161: 3469-3473.
148. Matsuzawa A, Ichijo H. (2005). Antioxid Redox Signal 7: 472-481.
149. Matta H, Chaudhary PM. (2004). Proc Natl Acad Sci USA 101: 9399-9404.
150. Matta H, Chaudhary PM. (2005). Cancer Biol Ther 4: 77-82.
151. Mattson MP, Camandola S. (2001). J Clin Invest 107: 247-254.
152. Mattson MP, Meffert MK. (2006). Cell Death Differ 13: 852-860.
153. Meffert MK, Baltimore D. (2005). Trends Neurosci 28: 37-43.
154. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. (2003). Nat Neurosci 6: 1072-1078.
155. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. (2001). Mol Cell Biol 21: 5299-5305.
156. Micheau O, Tschopp J. (2003). Cell 114: 181-190.
157. Mittal A, Papa S, Franzoso G, Sen R. (2006). J Immunol 176: 2183-2189.
158. Munzert G, Kirchner D, Ottmann O, Bergmann L, Schmid RM. (2004). Leuk Lymphoma 45: 1181-1184.
159. Nakanishi C, Toi M. (2005). Nat Rev Cancer 5: 297-309.
160. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K. (2006). Cell Death Differ 13: 730-737.
161. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW. (1997). Mol Cell Biol 17: 3629-3639.
162. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G et al. (2006). Nature 441: 106-110.
163. Nicot C, Mahieux R, Takemoto S, Franchini G. (2000). Blood 96: 275-281.
164. Owyang AM, Tumang JR, Schram BR, Hsia CY, Behrens TW, Rothstein TL et al. (2001). J Immunol 167: 4948-4956.
165. Pahl HL. (1999). Oncogene 18: 6853-6866.
166. Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR et al. (2006). Cell Death Differ 13: 712-729.
167. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S et al. (2004a). Nat Cell Biol 6: 146-153.
168. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. (2004b). J Cell Sci 117: 5197-5208.
169. Park MY, Jang HD, Lee SY, Lee KJ, Kim E. (2004). J Biol Chem 279: 2544-2549.
170. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V et al. (2005). Nature 437: 759-763.
171. Perkins ND, Gilmore TD. (2006). Cell Death Differ 13: 759-772.
172. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K et al. (2004). Cell 119: 529-542.
173. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. (2004). Nature 431: 461-466.
174. Prendes M, Zheng Y, Beg AA. (2003). J Immunol 171: 3963-3969.
175. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C et al. (2001). Nat Cell Biol 3: 409-416.
176. Rayet B, Gélinas C. (1999). Oncogene 18: 6938-6947.
177. Reiley WW, Zhang M, Sun S-C. (2004). J Biol Chem 279: 55161-55167.
178. Reiley WW, Zhang M, Jin W, Losiewicz M, Donohue KB, Norbury CC et al. (2006). Nat Immunol 7: 411-417.
179. Rivera-Walsh I, Waterfield M, Xiao G, Fong A, Sun S-C. (2001). J Biol Chem 276: 40385-40388.
180. Rocha S, Campbell KJ, Perkins ND. (2003a). Mol Cell 12: 15-25.
181. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. (2005). EMBO J 24: 1157-1169.
182. Rocha S, Martin AM, Meek DW, Perkins ND. (2003b). Mol Cell Biol 23: 4713-4727.
183. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J et al. (2000). Genes Dev 14: 854-862.
184. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G et al. (2003). Mol Cell 12: 1413-1426.
185. Saccani S, Marazzi I, Beg AA, Natoli G. (2004). J Exp Med 200: 107-113.
186. Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y et al. (2003). EMBO J 22: 3898-3909.
187. Santoro MG, Rossi A, Amici C. (2003). EMBO J 22: 2552-2560.
188. Schauvliege R, Vanrobaeys J, Schotte P, Beyaert R. (2002). J Biol Chem 277: 41624-41630.
189. Scheidereit C. (2006). Oncogene 25: 6685-6705.
190. Schwenzer R, Siemienski K, Liptay S, Schubert G, Peters N, Scheurich P et al. (1999). J Biol Chem 274: 19368-19374.
191. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. (2000). Cancer Res 60: 4085-4092.
192. Seitz CS, Lin Q, Deng H, Khavari PA. (1998). Proc Natl Acad Sci USA 95: 2307-2312.
193. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. (1990). J Exp Med 171: 35-47.
194. Shen L, Guo J, Santos-Berrios C, Wu MX. (2006). J Biol Chem 281: 15304-15311.
195. Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE et al. (2006). EMBO J 25: 129-138.
196. Shipp M, Ross K, Tamayo P, Weng AP, Kutok JL, Aguiar RCT et al. (2002). Nat Med 8: 68-74.
197. Shishodia S, Sethi G, Konopleva M, Andreeff M, Aggarwal BB. (2006). Clin Cancer Res 12: 1828-1838.
198. Shou Y, Li N, Li L, Borowitz JL, Isom GE. (2002). J Neurochem 81: 842-852.
199. Siebenlist U, Brown K, Claudio E. (2005). Nat Rev Immunol 5: 435-445.
200. Siegmund D, Hausser A, Peters N, Scheurich P, Wajant H. (2001). J Biol Chem 276: 43708-43712.
201. Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E. (2006). Proc Natl Acad Sci USA 103: 2689-2694.
202. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). J Clin Invest 100: 2952-2960.
203. Stark LA, Dunlop MG. (2005). Mol Cell Biol 25: 5985-6004.
204. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. (1998). J Exp Med 188: 211-216.
205. Steinbrecher KA, Wilson III W, Cogswell PC, Baldwin AS. (2005). Mol Cell Biol 25: 8444-8455.
206. Stoffel A, Chaurushiya M, Singh B, Levine AJ. (2004). Proc Natl Acad Sci USA 101: 9079-9084.
207. Strozyk E, Pöppelmann B, Schwarz T, Kulms D. (2006). Oncogene (in press).
208. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J et al. (2005). Science 307: 1465-1468.
209. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A et al. (2004). Cancer Cell 6: 347-360.
210. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS et al. (1998). J Biol Chem 273: 7787-7790.
211. Tamatani M, Che Y, Matsuzaki H, Ogawa S, Okado H, Miyake S et al. (1999). J Biol Chem 274: 8531-8538.
212. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C et al. (2002). Mol Cell 9: 1017-1029.
213. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL et al. (1999). Immunity 10: 421-429.
214. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M et al. (2001). Nature 414: 313-317.
215. Tao Y, Yan D, Yang Q, Zeng R, Wang Y. (2006). Mol Cell Biol 26: 1038-1050.
216. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. (2002). Cancer Cell 1: 493-503.
217. Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G et al. (1999). J Virol 73: 7981-7987.
218. Van Antwerp DJ, Martin SJ, Verma IM, Green DR. (1998). Cell Biol 8: 107-111.
219. van Hogerlinden M, Rozell BL, hrlund-Richter L, Toftgård R. (1999). Cancer Res 59: 3299-3303.
220. Ventura JJ, Cogswell P, Flavell RA, Baldwin Jr AS, Davis RJ. (2004). Genes Dev 18: 2905-2915.
221. Wang CY, Guttridge DC, Mayo MW, Baldwin Jr AS. (1999). Mol Cell Biol 19: 5923-5929.
222. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. (1998). Science 281: 1680-1683.
223. Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN. (2004). Lab Invest 84: 941-951.
224. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. (2004). Nature 430: 694-699.
225. White DW, Gilmore TD. (1996). Oncogene 13: 891-899.
226. Wilkinson JC, Wilkinson AS, Scott FL, Csomos RA, Salvesen GS, Duckett CS. (2004). J Biol Chem 279: 51082-51090.
227. Wolff B, Naumann M. (1999). Oncogene 18: 2663-2666.
228. Wright CW, Duckett CS. (2005). J Clin Invest 115: 2673-2678.
229. Wu H, Lozano G. (1994). J Biol Chem 269: 20067-20074.
230. Wu L, Nakano H, Wu Z. (2006). J Biol Chem 281: 2162-2169.
231. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D et al. (1996). EMBO J 15: 4682-4690.
232. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. (1999). J Biol Chem 274: 27307-27314.
233. Yamazaki T, Kurosaki T. (2003). Nat Immunol 4: 780-786.
234. Yin M-J, Yamamoto Y, Gaynor RB. (1998). Nature 396: 77-80.
235. You M, Ku PT, Hrdlickova R, Bose Jr HR. (1997). Mol Cell Biol 17: 7328-7341.
236. You Z, Madrid LV, Saims D, Sedivy J, Wang CY. (2002). J Biol Chem 277: 36671-36677.
237. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ et al. (2004). Hepatology 40: 1312-1321.
238. Zazzeroni F, Papa S, Algeciras-Schimnich A, Alvarez K, Melis T, Bubici C et al. (2003a). Blood 102: 3270-3279.
239. Zazzeroni F, Papa S, De Smaele E, Franzoso G. (2003b). Nature 424: 742.
240. Zeh III HJ, Lotze MT. (2005). J Immunother 28: 1-9.
241. Zhang JY, Green CL, Tao S, Khavari PA. (2004). Genes Dev 18: 17-22.
242. Zhang JY, Tao S, Kimmel R, Khavari PA. (2005). J Cell Biol 168: 561-566.
243. Zheng L, Bidere N, Staudt D, Cubre A, Orenstein J, Chan FK et al. (2006). Mol Cell Biol 26: 3505-3513.
244. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA. (2001). J Immunol 166: 4949-4957.
245. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M et al. (2004). Nature 427: 167-171.
246. Zong WX, Edelstein LC, Chen C, Bash J, Gélinas C. (1999). Genes Dev 13: 382-387.